United States Anti-Cancer Injectable Industry 2017 Market Research Report

 Table of Contents

United States Anti-Cancer Injectable Market Report 2017
1 Anti-Cancer Injectable Overview
    1.1 Product Overview and Scope of Anti-Cancer Injectable
    1.2 Classification of Anti-Cancer Injectable by Product Category
        1.2.1 United States Anti-Cancer Injectable Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Anti-Cancer Injectable Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Chemical Medicine Injectable
        1.2.4 Traditional Chinese Medicine Injectable
    1.3 United States Anti-Cancer Injectable Market by Application/End Users
        1.3.1 United States Anti-Cancer Injectable Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 United States Anti-Cancer Injectable Market by Region
        1.4.1 United States Anti-Cancer Injectable Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Anti-Cancer Injectable Status and Prospect (2012-2022)
        1.4.3 Southwest Anti-Cancer Injectable Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Anti-Cancer Injectable Status and Prospect (2012-2022)
        1.4.5 New England Anti-Cancer Injectable Status and Prospect (2012-2022)
        1.4.6 The South Anti-Cancer Injectable Status and Prospect (2012-2022)
        1.4.7 The Midwest Anti-Cancer Injectable Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Anti-Cancer Injectable (2012-2022)
        1.5.1 United States Anti-Cancer Injectable Sales and Growth Rate (2012-2022)
        1.5.2 United States Anti-Cancer Injectable Revenue and Growth Rate (2012-2022)

2 United States Anti-Cancer Injectable Market Competition by Players/Suppliers
    2.1 United States Anti-Cancer Injectable Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Anti-Cancer Injectable Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Anti-Cancer Injectable Average Price by Players/Suppliers (2012-2017)
    2.4 United States Anti-Cancer Injectable Market Competitive Situation and Trends
        2.4.1 United States Anti-Cancer Injectable Market Concentration Rate
        2.4.2 United States Anti-Cancer Injectable Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Anti-Cancer Injectable Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anti-Cancer Injectable Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Anti-Cancer Injectable Sales and Market Share by Region (2012-2017)
    3.2 United States Anti-Cancer Injectable Revenue and Market Share by Region (2012-2017)
    3.3 United States Anti-Cancer Injectable Price by Region (2012-2017)

4 United States Anti-Cancer Injectable Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Anti-Cancer Injectable Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Anti-Cancer Injectable Revenue and Market Share by Type (2012-2017)
    4.3 United States Anti-Cancer Injectable Price by Type (2012-2017)
    4.4 United States Anti-Cancer Injectable Sales Growth Rate by Type (2012-2017)

5 United States Anti-Cancer Injectable Sales (Volume) by Application (2012-2017)
    5.1 United States Anti-Cancer Injectable Sales and Market Share by Application (2012-2017)
    5.2 United States Anti-Cancer Injectable Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Anti-Cancer Injectable Players/Suppliers Profiles and Sales Data
    6.1 Eli Lilly
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Eli Lilly Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Chiron
        6.2.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Chiron Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Celgene Inc
        6.3.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Celgene Inc Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Ferring Pharmaceuticals
        6.4.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ferring Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Johnson & Johnson
        6.5.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Johnson & Johnson Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Jazz Pharmaceuticals
        6.6.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Jazz Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Spectrum Pharmaceuticals
        6.7.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Spectrum Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Takeda Pharmaceuticals
        6.8.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Takeda Pharmaceuticals Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Genzyme
        6.9.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Genzyme Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 GSK
        6.10.2 Anti-Cancer Injectable Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 GSK Anti-Cancer Injectable Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Sandoz
    6.12 Pharmascience
    6.13 Admac Lifesciences
    6.14 Fresenius Kabi Oncology Limited
    6.15 Jiangsu Hengrui Medicine
    6.16 Nanjing Cisco Pharmaceuticals
    6.17 Jiangsu Hengrui Medicine
    6.18 Shanghai Roche
    6.19 Jiangsu Haosen Pharmaceutical
    6.20 F Hoffmann-La Roche Ltd (SW)
    6.21 France Masi Pu (China) Pharmaceuticals

7 Anti-Cancer Injectable Manufacturing Cost Analysis
    7.1 Anti-Cancer Injectable Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anti-Cancer Injectable

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anti-Cancer Injectable Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anti-Cancer Injectable Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Anti-Cancer Injectable Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Anti-Cancer Injectable Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Anti-Cancer Injectable Sales Volume Forecast by Type (2017-2022)
    11.3 United States Anti-Cancer Injectable Sales Volume Forecast by Application (2017-2022)
    11.4 United States Anti-Cancer Injectable Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Anti-Cancer Injectable
    Figure United States Anti-Cancer Injectable Market Size (Million Units) by Type (2012-2022)
    Figure United States Anti-Cancer Injectable Sales Volume Market Share by Type (Product Category) in 2016
    Figure Chemical Medicine Injectable Product Picture
    Figure Traditional Chinese Medicine Injectable Product Picture
    Figure United States Anti-Cancer Injectable Market Size (Million Units) by Application (2012-2022)
    Figure United States Sales Market Share of Anti-Cancer Injectable by Application in 2016
    Figure Hospital Examples
    Figure Clinic Examples
    Figure Other Examples
    Figure United States Anti-Cancer Injectable Market Size (Million USD) by Region (2012-2022)
    Figure The West Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Anti-Cancer Injectable Sales (Million Units) and Growth Rate (2012-2022)
    Figure United States Anti-Cancer Injectable Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Anti-Cancer Injectable Market Major Players Product Sales Volume (Million Units) (2012-2017)
    Table United States Anti-Cancer Injectable Sales (Million Units) of Key Players/Suppliers (2012-2017)
    Table United States Anti-Cancer Injectable Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Anti-Cancer Injectable Sales Share by Players/Suppliers
    Figure 2017 United States Anti-Cancer Injectable Sales Share by Players/Suppliers
    Figure United States Anti-Cancer Injectable Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Anti-Cancer Injectable Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Anti-Cancer Injectable Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Anti-Cancer Injectable Revenue Share by Players/Suppliers
    Figure 2017 United States Anti-Cancer Injectable Revenue Share by Players/Suppliers
    Table United States Market Anti-Cancer Injectable Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
    Figure United States Market Anti-Cancer Injectable Average Price (USD/Unit) of Key Players/Suppliers in 2016
    Figure United States Anti-Cancer Injectable Market Share of Top 3 Players/Suppliers
    Figure United States Anti-Cancer Injectable Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Anti-Cancer Injectable Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Anti-Cancer Injectable Product Category
    Table United States Anti-Cancer Injectable Sales (Million Units) by Region (2012-2017)
    Table United States Anti-Cancer Injectable Sales Share by Region (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Share by Region (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Market Share by Region in 2016
    Table United States Anti-Cancer Injectable Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Anti-Cancer Injectable Revenue Share by Region (2012-2017)
    Figure United States Anti-Cancer Injectable Revenue Market Share by Region (2012-2017)
    Figure United States Anti-Cancer Injectable Revenue Market Share by Region in 2016
    Table United States Anti-Cancer Injectable Price (USD/Unit) by Region (2012-2017)
    Table United States Anti-Cancer Injectable Sales (Million Units) by Type (2012-2017)
    Table United States Anti-Cancer Injectable Sales Share by Type (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Share by Type (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Market Share by Type in 2016
    Table United States Anti-Cancer Injectable Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Anti-Cancer Injectable Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Anti-Cancer Injectable by Type (2012-2017)
    Figure Revenue Market Share of Anti-Cancer Injectable by Type in 2016
    Table United States Anti-Cancer Injectable Price (USD/Unit) by Types (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Growth Rate by Type (2012-2017)
    Table United States Anti-Cancer Injectable Sales (Million Units) by Application (2012-2017)
    Table United States Anti-Cancer Injectable Sales Market Share by Application (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Market Share by Application (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Market Share by Application in 2016
    Table United States Anti-Cancer Injectable Sales Growth Rate by Application (2012-2017)
    Figure United States Anti-Cancer Injectable Sales Growth Rate by Application (2012-2017)
    Table Eli Lilly Basic Information List
    Table Eli Lilly Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Eli Lilly Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Eli Lilly Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Eli Lilly Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Chiron Basic Information List
    Table Chiron Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Chiron Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Chiron Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Chiron Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Celgene Inc Basic Information List
    Table Celgene Inc Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Celgene Inc Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Celgene Inc Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Celgene Inc Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Ferring Pharmaceuticals Basic Information List
    Table Ferring Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Ferring Pharmaceuticals Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Ferring Pharmaceuticals Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Ferring Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Johnson & Johnson Basic Information List
    Table Johnson & Johnson Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Johnson & Johnson Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Johnson & Johnson Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Johnson & Johnson Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Jazz Pharmaceuticals Basic Information List
    Table Jazz Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Jazz Pharmaceuticals Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Jazz Pharmaceuticals Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Jazz Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Spectrum Pharmaceuticals Basic Information List
    Table Spectrum Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Spectrum Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Takeda Pharmaceuticals Basic Information List
    Table Takeda Pharmaceuticals Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Takeda Pharmaceuticals Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Takeda Pharmaceuticals Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Takeda Pharmaceuticals Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Genzyme Basic Information List
    Table Genzyme Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Genzyme Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure Genzyme Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure Genzyme Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table GSK Basic Information List
    Table GSK Anti-Cancer Injectable Sales (Million Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure GSK Anti-Cancer Injectable Sales Growth Rate (2012-2017)
    Figure GSK Anti-Cancer Injectable Sales Market Share in United States (2012-2017)
    Figure GSK Anti-Cancer Injectable Revenue Market Share in United States (2012-2017)
    Table Sandoz Basic Information List
    Table Pharmascience Basic Information List
    Table Admac Lifesciences Basic Information List
    Table Fresenius Kabi Oncology Limited Basic Information List
    Table Jiangsu Hengrui Medicine Basic Information List
    Table Nanjing Cisco Pharmaceuticals Basic Information List
    Table Jiangsu Hengrui Medicine Basic Information List
    Table Shanghai Roche Basic Information List
    Table Jiangsu Haosen Pharmaceutical Basic Information List
    Table F Hoffmann-La Roche Ltd (SW) Basic Information List
    Table France Masi Pu (China) Pharmaceuticals Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Anti-Cancer Injectable
    Figure Manufacturing Process Analysis of Anti-Cancer Injectable
    Figure Anti-Cancer Injectable Industrial Chain Analysis
    Table Raw Materials Sources of Anti-Cancer Injectable Major Players/Suppliers in 2016
    Table Major Buyers of Anti-Cancer Injectable
    Table Distributors/Traders List
    Figure United States Anti-Cancer Injectable Sales Volume (Million Units) and Growth Rate Forecast (2017-2022)
    Figure United States Anti-Cancer Injectable Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Anti-Cancer Injectable Price (USD/Unit) Trend Forecast (2017-2022)
    Table United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Type (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Type (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Type in 2022
    Table United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Application (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Application (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Application in 2022
    Table United States Anti-Cancer Injectable Sales Volume (Million Units) Forecast by Region (2017-2022)
    Table United States Anti-Cancer Injectable Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Anti-Cancer Injectable Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy